AACR 2009: Genetic influences in acknowledgment to EGFR for metastatic colorectal cancer

Frederica Di Nicolantonio, Pharm.D., Ph.D., research fellow, Laboratory of Molecular Genetics, The Institute for Cancer Research and Treatment, University of Turin Medical School, speaking at AACR 2009, Denver: BRAF, PIK3CA and KRAS Mutations and Loss of PTEN Expression Impair Response to EGFR-Targeted Therapies in Metastatic Colorectal Cancer



http://www.youtube.com/watch?v=ItDUkalwv4Y&hl=en